Description: Come hear about the latest trends and insights as this panel discusses the happenings in life insurance marketplace. The panel plans to cover product, regulatory, underwriting, marketing, and other trends to help keep the audience up to date on many of Life's changing events.

Description: Actuaries historically modeled new launches in pharmaceuticals by anticipating the expected change to the market basket. This became more complicated with the recent launches of gene and cell therapies as they address rare diseases. Rare conditions have low total member volume to study and some do not currently have a diagnosis code to identify them within claims data. Addressing this modeling challenge has been growing more important in the recent years with the number of therapies launching. What has the health care industry, and more specifically health care, done to enhance modeling and how should this be altered for the future? Additionally, historic modeling has sometimes incorporated a level of direct medical treatment cost offsets where studies have shown lower treatment costs are achievable. Can gene and cell financial modeling include cost offsets as well? And if so, what are suggested precautions or limitations to this effort?

Description: Many states have recently introduced mandatory paid family and medical leave (PFML) programs, which require employers to provide PFML benefits to their employees. This session explores recent trends in PFML programs, including plan design, pricing, employee perception, employer challenges, and current activity in various states.

Description: "Given the typical career trajectory of an actuary starts with increasing technical skill, we often overlook developing our communication skills, much to the determent of our overall career growth and business effectiveness. The only way that our work turns into business action is through communication, and business action is the sole purpose of our analyses. Come explore several ways to communicate more effectively by developing an understanding of our audience and what their “win” is, focusing on developing impactful messaging and outlining clear action, and how networking, especially broadly across the organization, can help us communicate more effectively. After this session you will be able to: Understand your audience and tailor your communication appropriately Develop clear messaging and explanations and deliver next steps Understanding how broadening your network can help you communicate more effectively"

Description: Enjoy an in-depth walkthrough of the facets of the lab testing world in this webcast. The agenda will include a discussion on genetic testing, which focuses on its general background, current trends and tests in the pipeline, as well as a focus on the approaches to achieve savings in lab testing. Finally, expect to check out sample actuarial analyses that will be used to identify areas of focus in lab management. Join us and take a deeper look into lab work in the actuarial health industry.

Description: Renal disease is a very heterogenous medical condition whose end state is dialysis, a recurring cost intensive medical condition. Dialysis cost is one of the major medical cost drivers in USA. Insufficient and improper care management in the early stages of CKD (chronic kidney disease) leads to early incidence of end stage renal disease (ESRD) among CKD patients which not only leads to high medical costs, but also reflects poor health quality.

Description: In this video Mitchell Momanyi, FSA MAAA presents an informative breakdown of Medicare Advantage plans, delving into the intricacies of this alternative to traditional Medicare. Covering the inception of Medicare Advantage and its evolution, Momanyi explores the managed care companies offering Part C coverage, emphasizing the role of provider networks coordinated care. Concluding with key considerations for beneficiaries, Momanyi stresses the importance of weighing the pros and cons between Traditional Medicare and Medicare Advantage, while also emphasizing the evolving nature of the Medicare landscape and the regulatory nuances influencing enrollment decisions. Conributors: Mitchell Momanyi, FSA, MAAA, Deana Bell FSA, MAAA, Matt Emery, FSA, CERA, MAAA, Jon Forster, ASA, MAAA

Description: In this video Dale Hall, Managing Director of Research at the Society of Actuaries Research Institute, introduces a report titled “Guide to Domestic & International Paid Family and Medical Leave Programs.” Motivated by the increasing interest in these programs, especially post-COVID 19, the report compares U.S. and international paid family and medical leave initiatives. Key findings include differences in benefit generosity and periods for maternity and paternity leave, as well as domestic violence leave. Contributors: Dale Hall FSA, MAAA, CFA, CERA , Rose Northon, STeven Siegel ASA MAAA, Jon Forster ASA MAAA

Description: Creating a predictive model is one thing, but then taking that model and getting full stakeholder buy-in is another. Learn from presenters' experiences and insights on proving model effectiveness in the long-term care (LTC), life and annuity spaces. Explore various topics such as feasibility, model transparency, fairness and equity, ROI measurement, data assets and compliance, infrastructure and more. By the end of the session, you will gain an understanding of how to navigate the challenges of proving the effectiveness of predictive modeling and obtaining management buy-in.

Description: Cover a variety of topics centered around the unsupervised learning technique called 'clustering'. The presenters will take you through a wide array of topics that range from 'What is Clustering?' to 'How can I use this technique to solve problems I didn't even know existed?' In the health care industry, everyone is looking for an edge in reducing total spend-cluster analysis finds the unambiguous in an ambiguous framework of results.